MG billed itself as “the sports car that America loved first ... Run of 6682 North American Limited Editions starts. 1980: 17 character VIN and 80 mph speedometer. Final cars produced in October of ...

I pazienti affetti da rari problemi ereditari di intolleranza al galattosio, da deficit totale di lattasi, o da malassorbimento di glucosio-galattosio, non devono assumere questo medicinale. Gli studi ...

compresse di Aristos P 20 mg: 1; compresse di Aristos P 80 mg: ¼ Peso dell'animale: 12-17 kg; compresse di Aristos P 10 mg: 3; compresse di Aristos P 20 mg: 1+½ Peso dell'animale: 17-25 kg; compresse ...

The new ETFs' attractive initial cap rates complement the already launched 100% (CBOJ) protection ETF, providing investors with a combination of protection levels and upside potential unavailable ...

According to Barry Jackson of the Miami Herald, the Heat are determined to clear over $80 million in cap space to prepare for one of the most anticipated free-agent classes in years. This decision ...

Indian Stock Market: Retail investors' most favoured small-cap stocks are at the forefront ... According to the Trendlyne data, 80 stocks from the Nifty Smallcap 100 basket are currently trading ...

Neurocrine Biosciences Q4 EPS of $1.69 beat estimates, while revenue missed consensus. Ingrezza sales rose 23% to $615 million. 2025 Ingrezza sales guidance fell short of Street estimate.

INGREZZA Sales Guidance for 2025: $2.5 billion to $2.6 billion, reflecting $250 million growth at the midpoint. CRENESSITY Q4 2024 Sales: $2 million in net sales from initial bottle orders.

He emphasized the strong performance of INGREZZA, which is poised for double-digit year-over-year growth despite moderated expectations compared to 2024, the company’s highest growth year to date.

On Thursday, Neurocrine Biosciences Inc. (NASDAQ:NBIX) reported fourth-quarter adjusted EPS of $1.69, higher than the $1.54 reported a year ago, beating the consensus of $1.56. The company ...

Dead money, for those unaware, is the NFL term used for any salary cap charge left on the books once a player is no longer on the roster. The Saints, for instance, will allocate nearly $31.7 ...

FY25 revenue consensus $2.79B. Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Monitor your stock ...